24 May 2013
Keywords: novartis, nine-month, net, income, leaps, swiss, pharmaceutical
Article | 25 October 2004
Swiss pharmaceutical leader Novartis has posted a strong set of results for the nine months to September 30, 2004, but disappointed the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 October 2004
23 May 2013
© 2013 thepharmaletter.com